Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Amedra Pharmaceuticals LLC

Division of Amneal Pharmaceuticals LLC
www.amedrapharma.com

Latest From Amedra Pharmaceuticals LLC

Keeping Track: A Long-Awaited Approval For Generic EpiPen, Cancer Product Labels Expand And Constrict

The latest drug development news and highlights from our US FDA Performance Tracker. 
Drug Review Regulation

EpiPen Pricing Got Mylan In Hot Water; Now Sanofi Is Taking Firm To Court

Sanofi claims Mylan blocked its competing Auvi-Q product from the market by offering rebates to payers on the condition they would only reimburse for EpiPen; Sanofi seeks treble damages for lost sales.

BioPharmaceutical Policy

ANDAs For Drug/Device Combos Face High Bar At US FDA; Epipen, Advair May Benefit

Generics must be able to be administered without provider intervention or patient retraining, draft guidance says.

Combination Products Generic Drugs

ANDAs For Drug/Device Combos Face High Bar At US FDA; Epipen, Advair May Benefit

Generics must be able to be administered without provider intervention or patient retraining, draft guidance says.

Combination Products Generic Drugs
See All

Company Information

  • Industry
  • Medical Devices
  • Pharmaceuticals
  • Therapeutic Areas
  • Immune Disorders
  • Infectious & Viral Diseases
  • Neurology, Nervous System
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Amneal Pharmaceuticals LLC
  • Senior Management
  • Christopher Worrell, CEO
    Thomas Versosky, VP, Sales & Mktg.
    Michael Tuterice, Corp. Controller
  • Contact Info
  • Amedra Pharmaceuticals LLC
    Phone: (215) 259-3601
    2 Walnut Grove Dr.
    Ste. 190
    Horsham, PA 19044-7707
    USA
UsernamePublicRestriction

Register